Neonatal candidemia can occur, however, infections caused by Candida pelliculosa are rare. Here, we describe an outbreak of candidemia caused by C. pelliculosa among babies hospitalized in a neonatal intensive care unit.
The entomopathogenic fungi of the genus Metarhizium have several
subtilisin-like proteases that are involved in pathogenesis and these have been used
to investigate genes that are differentially expressed in response to different
growth conditions. The identification and characterization of these proteases can
provide insight into how the fungus is capable of infecting a wide variety of insects
and adapt to different substrates. In addition, the pr1A gene has
been used for the genetic improvement of strains used in pest control. In this study
we used quantitative RT-PCR to assess the relative expression levels of the
pr1A gene in M. anisopliae and M.
acridum during growth in different culture conditions and during
infection of the sugar cane borer, Diatraea saccharalis Fabricius.
We also carried out a pathogenicity test to assess the virulence of both species
against D. saccharalis and correlated the results with the pattern
of pr1A gene expression. This analysis revealed that, in both
species, the pr1A gene was differentially expressed under the growth
conditions studied and during the pathogenic process. M. anisopliae
showed higher expression of pr1A in all conditions examined, when
compared to M. acridum. Furthermore, M. anisopliae
showed a greater potential to control D. saccharalis. Taken
together, our results suggest that these species have developed different strategies
to adapt to different growing conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.